The FDA guidance on adaptive trials (group sequential designs, sample size re-estimation, and so forth) can be found
here. I've only skimmed through it but it looks fairly informative. So far so good. Hopefully this will be a strong document that will lead to an increase in these kinds of studies.
I'll discuss more after a more thorough look.